Table 4.

Response of liver metastases to ongoing treatments at the description of diffuse hepatic contour abnormalities and to the previous line of treatment according to CT or MRI protocols (n=48)

Response	Ongoing treatment n (%) (95% CI for %)	Previous treatment n (%) (95% CI for %)
Complete	0 (0) (0 to 7.4)	0 (0) (0 to 7.4)
Partial	25 (52.1) (38.3 to 65.5)	16 (33.3) (21.7 to 47.5)
Stable	16 (33.3) (21.7 to 47.5)	8 (16.7) (8.7 to 29.6)
Progression	5 (10.4) (4.5 to 22.2)	11 (22.9) (13.3 to 36.5)
Not evaluable or applicable	2 (4.2) (1.2 to 14.0)*	13 (27.1) (16.6 to 41.0)†
P value: test of Χ²‡	0.021

*In two patients, diffuse hepatic contour abnormalities were identified on positron emission tomography, with the absence of contrast injection making it impossible to assess the lesions using tomography images.

†Six patients had diffuse liver contour abnormalities during their first line of treatment.

‡Excluding not evaluable or applicable patients.

N, number of patients analysed; n, number of patients in the category.